Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Hantaan virus glycoprotein complex, known as Gn-Gc, forms the outer envelope spikes on hantavirus virions and mediates critical early infection steps. Encoded by the viral M segment as a precursor glycoprotein (GPC) that is cleaved into Gn (G1) and Gc (G2), the complex assembles into a lattice with four-fold symmetry on the pleomorphic viral membrane. Gn primarily handles host cell receptor recognition and attachment, facilitating clathrin-mediated endocytosis, while Gc acts as the class II membrane fusion protein that, in response to endosomal low pH (around 5.9-6.3), undergoes conformational changes to expose a hydrophobic fusion loop, insert into the host membrane, and drive viral-host membrane fusion for genome delivery. Crystal structures confirm Gc's post-fusion trimeric form with three β-barrel domains (I-III), disulfide bonds, and N-linked glycosylation stabilizing the assembly, while Gn's ectodomain structure shows conservation across hantaviruses. In Hantaan virus, the most prevalent pathogenic hantavirus causing hemorrhagic fever with renal syndrome, this complex is essential for entry into host cells like endothelial and immune cells. Neutralizing antibodies target conformational epitopes on Gn-Gc, blocking attachment or fusion, highlighting its role as a key antiviral target, though no approved drugs exist. The glycoproteins also interact with host nucleoprotein tails, potentially evading antiviral responses like PKR-mediated interferon induction.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hantaan virus glycoprotein complex (Gn-Gc) (Gn-Gc).